Dosing regimen for treating inflammatory bowel disease
US12304956B1 · kind B1 · utility
1Cited by
69References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 2024 |
| Grant date | May 20, 2025 |
| Priority date | — |
| Expiry date | Jul 16, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are variant α4β7 integrin antibodies and methods of use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.